AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Aptitude Software Group PLC

Declaration of Voting Results & Voting Rights Announcements Sep 4, 2018

5267_rns_2018-09-04_5f2b9544-2720-4329-840d-6e370cccbe65.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7552Z

Microgen PLC

04 September 2018

4 September 2018

MICROGEN plc

Block Listing Application

Microgen plc (LSE: MCGN), a leading provider of business critical software and services, provides notification that application has been made to the UK Listing Authority and the London Stock Exchange for the block listing for general business purposes of 1,632,500 ordinary shares of 6 3/7 pence each, to be admitted to the Official List of the UKLA and to the London Stock Exchange for the Shares to be admitted to trading on its main market.

The purpose of the block listing is to satisfy options awarded under:

(i) the Microgen Plc Performance Share Plan 2006 (1,532,500 ordinary shares); and

(ii) the Microgen Plc Save As You Earn Scheme 2016 and International Sharesave Scheme 2016 (100,000 ordinary shares).

It is expected that admission will become effective on 7 September 2018. Any shares will, when issued, rank pari passu with the existing ordinary shares of the company.

Contacts

Philip Wood, Chief Financial Officer                                   020-7496-8100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ALSUGURPBUPRGAC

Talk to a Data Expert

Have a question? We'll get back to you promptly.